HealthTech

Malaysia-based private equity firm Creador announced Monday its investment into La Renon Healthcare by acquiring a 7 percent stake from the promoter and existing investor Peak XV Partners (formerly Sequoia India).

AdipoLABs Co., Ltd. and Red & Blue Co., Ltd. from South Korea, together with their Malaysian subsidiary, AdipoLABs Healthcare (M) Sdn Bhd, have officially opened the new AdipoLABs regional office for Asia-Pacific, marking a strategic expansion to strengthen its leadership in non- invasive healthcare and build a robust MedTech ecosystem in Malaysia and…

Pride Health, a Thailand-based company and Asia’s first LGBTQ+ digital healthcare platform, has raised $300,000 in a pre-seed round with A2D Ventures, Enterprise Singapore, First Move, and depa’s Digital Startup Fund (S2).

The digital transformation of the pharmaceutical industry is no longer a matter of whether to invest, but a race to see who can achieve it fastest. From multinational pharmaceutical companies integrating AI into the heart of R&D to startups and CDMOs collaborating to build smart production lines, the Pharma 4.0 wave is rapidly taking shape worldwide.

Due to the influx of patients and the limited number of staff at medical facilities, the need for AI’s automated services has increased. While it may seem that the system's initial cost is the most expensive, there are numerous hidden costs that accumulate over time, which healthcare professionals must also be aware of.

Clinics embracing integrated digital platforms are seeing reduced burnout, better team morale, and fewer errors. These tools aren't just about efficiency—they’re about sustainability. By cutting operational costs and improving workflows, they help future-proof clinics while protecting patient outcomes.

TVM Capital Healthcare, a global private equity investor and operator specialized in healthcare growth capital across emerging markets, announced Wednesday the first closing of its $150 million TVM Healthcare Southeast Asia Fund (SEA Fund).

The APAC region faces several barriers to adopting AI in health care, but there are also many opportunities to embrace it. Nations should focus on continued innovation and collaboration to advance digital medical technology and take advantage of everything AI has to offer.

Wellous said the collaboration covers consumer insight-sharing for target markets, co-development of new business approaches, brand reputation building, as well as authorised sales and promotion of Jung Kwan Jang products by Wellous in designated countries.

An investigation into the $368 billion AI healthcare revolution — and the visionary CEO determined to make cancer a preventable disease.